Literature DB >> 26692024

Chronic haemodialysis in small children: a retrospective study of the Italian Pediatric Dialysis Registry.

Fabio Paglialonga1, Silvia Consolo2, Carmine Pecoraro3, Enrico Vidal4, Bruno Gianoglio5, Flora Puteo6, Stefano Picca7, Maria Teresa Saravo3, Alberto Edefonti2, Enrico Verrina8.   

Abstract

BACKGROUND: Chronic haemodialysis (HD) in small children has not been adequately investigated.
METHODS: This was a retrospective investigation of the use of chronic HD in 21 children aged  <2 years (n = 12 aged <1 year) who were registered in the Italian Pediatric Dialysis Registry. Data collected over a period of >10 years were analysed.
RESULTS: The median age of the 21 children at start of HD was 11.4 [interquartile range (IQR) 6.2-14.6] months, and HD consisted mainly of haemodiafiltration for 3-4 h in  ≥4 sessions/week. A total of 51 central venous catheters were placed, and the median survival of tunnelled and temporary lines was 349 and 31 days, respectively (p  < 0.001). Eight children (38 %) showed evidence of central vein thrombosis. Although 19 % of patients received growth hormone and 63.6 % received enteral feeding, the weight and height of these patients remained suboptimal. During the HD period the haemoglobin level increased in all patients, but not to normal levels (from 8.5 to 9.6 g/dl) despite erythropoietin administration (503-600 U/kg/week). The hospitalisation rate was 1.94/patient-year. Seventeen patients underwent renal transplantation at a median age of 3.0 years. Four patients, all affected by severe comorbidities, died during follow-up (in 2 cases due to absence of a vascular access). The 5- and 10-year cumulative survival was 82.4 and 68.7 %, respectively.
CONCLUSIONS: Extracorporeal dialysis is feasible in children aged  <2 years, but comorbidities, vascular access, growth and anaemia remain major concerns.

Entities:  

Keywords:  Central venous catheter; Extracorporeal dialysis; Haemodiafiltration; Paediatric dialysis modality; Young children

Mesh:

Year:  2015        PMID: 26692024     DOI: 10.1007/s00467-015-3272-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  25 in total

1.  Effects of automated peritoneal dialysis on residual daily urinary volume in children.

Authors:  M Fischbach; J Terzic; S Menouer; K Soulami; C Dangelser; A Helmstetter; F Gehant
Journal:  Adv Perit Dial       Date:  2001

2.  Outcomes of dialysis initiated during the neonatal period for treatment of end-stage renal disease: a North American Pediatric Renal Trials and Collaborative Studies special analysis.

Authors:  William A Carey; Lynya I Talley; Sally A Sehring; Janet M Jaskula; Robert S Mathias
Journal:  Pediatrics       Date:  2007-01-15       Impact factor: 7.124

3.  Improvement in growth after 1 year of growth hormone therapy in well-nourished infants with growth retardation secondary to chronic renal failure: results of a multicenter, controlled, randomized, open clinical trial.

Authors:  Fernando Santos; M Llanos Moreno; Arlete Neto; Gema Ariceta; Julia Vara; Angel Alonso; Alberto Bueno; Alberto Caldas Afonso; António Jorge Correia; Rafael Muley; Vicente Barrios; Carlos Gómez; Jesús Argente
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-03       Impact factor: 8.237

4.  Long-term outcome of chronic dialysis in children.

Authors:  Rukshana Shroff; Lesley Rees; Richard Trompeter; Carol Hutchinson; Sarah Ledermann
Journal:  Pediatr Nephrol       Date:  2005-11-04       Impact factor: 3.714

5.  Survival and transplantation outcomes of children less than 2 years of age with end-stage renal disease.

Authors:  R Todd Alexander; Bethany J Foster; Marcello A Tonelli; Andrea Soo; Alberto Nettel-Aguirre; Brenda R Hemmelgarn; Susan M Samuel
Journal:  Pediatr Nephrol       Date:  2012-06-07       Impact factor: 3.714

6.  The outcome of chronic dialysis in infants and toddlers--advantages and drawbacks of haemodialysis.

Authors:  Sofia Feinstein; Choni Rinat; Rachel Becker-Cohen; Efrat Ben-Shalom; Shepard B Schwartz; Yaacov Frishberg
Journal:  Nephrol Dial Transplant       Date:  2007-12-08       Impact factor: 5.992

7.  Survival and clinical outcomes of children starting renal replacement therapy in the neonatal period.

Authors:  Kariljn J van Stralen; Dagmara Borzych-Dużalka; Hiroshi Hataya; Sean E Kennedy; Kitty J Jager; Enrico Verrina; Carol Inward; Kai Rönnholm; Karel Vondrak; Bradley A Warady; Aleksandra M Zurowska; Franz Schaefer; Pierre Cochat
Journal:  Kidney Int       Date:  2014-02-05       Impact factor: 10.612

8.  A prospective cohort study of incident maintenance dialysis in children: an NAPRTC study.

Authors:  Mary B Leonard; Lynn A Donaldson; Martin Ho; Denis F Geary
Journal:  Kidney Int       Date:  2003-02       Impact factor: 10.612

9.  Aetiology and outcome of acute and chronic renal failure in infants.

Authors:  Mirja Wedekin; Jochen H H Ehrich; Gisela Offner; Lars Pape
Journal:  Nephrol Dial Transplant       Date:  2008-01-08       Impact factor: 5.992

10.  Clinical practice recommendations for the care of infants with stage 5 chronic kidney disease (CKD5).

Authors:  Aleksandra M Zurowska; Michel Fischbach; Alan R Watson; Alberto Edefonti; Constantinos J Stefanidis
Journal:  Pediatr Nephrol       Date:  2012-10-09       Impact factor: 3.714

View more
  3 in total

1.  Autologous arteriovenous fistulas for hemodialysis using microsurgery techniques in children weighing less than 20 kg.

Authors:  Vasiliki Karava; Pascal Jehanno; Theresa Kwon; Georges Deschênes; Marie-Alice Macher; Pierre Bourquelot
Journal:  Pediatr Nephrol       Date:  2017-12-05       Impact factor: 3.714

2.  End-stage kidney disease in infancy: an educational review.

Authors:  Keia R Sanderson; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2018-11-21       Impact factor: 3.714

3.  Infants with congenital nephrotic syndrome have comparable outcomes to infants with other renal diseases.

Authors:  Stephanie Dufek; Elisa Ylinen; Agnes Trautmann; Harika Alpay; Gema Ariceta; Christoph Aufricht; Justine Bacchetta; Sevcan Bakkaloglu; Aysun Bayazit; Salim Caliskan; Maria do Sameiro Faria; Ismail Dursun; Mesiha Ekim; Augustina Jankauskiene; Günter Klaus; Fabio Paglialonga; Andrea Pasini; Nikoleta Printza; Valerie Said Conti; Claus Peter Schmitt; Constantinos Stefanidis; Enrico Verrina; Enrico Vidal; Hazel Webb; Argyroula Zampetoglou; Alberto Edefonti; Tuula Holtta; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2018-10-29       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.